top of page



Kardium Inc. is a rapidly growing medical solutions company that has developed an advanced system for the treatment of atrial fibrillation (AF). AF, which affects more than 37 million people worldwide,  is an electrical disorder of the upper chambers of the heart (the atria) that causes rapid electrical signals that can exceed one hundred beats per minute. AF can severely impact quality of life and can increase the risk of stroke by 500%.

Founded in 2007 and  headquartered in Vancouver, Canada, Kardium is recognized as a top company to work for and makes a positive impact everyday.   




MOLLI Surgical started in the operating room, where surgeons were using dated tools to treat cancer patients — and we knew we could do better. Our surgical wand is precise, easy-to-use and built with the realities of the operating room in mind. More importantly, it is built with patients in mind. Our technology replaces a procedure to mark tumors that are traumatic and uncomfortable with one that is not only kinder — but more accurate, efficient and cost-effective. MOLLI Surgical is proud to build the advanced equipment that patients prefer to have and that physicians prefer to use.

CCRM Anniversary logo large.jpg



CCRM, a Canadian not-for-profit organization funded by the Government of Canada and leading academic and industry partners, supports the development of regenerative medicines and associated enabling technologies, with a specific focus on cell and gene therapy. A network of academic researchers, leading companies, strategic investors and entrepreneurs, CCRM accelerates the translation of scientific discovery into new companies and marketable products for patients, with specialized teams, funding and infrastructure. CCRM sources and evaluates intellectual property from around the globe, offers various consulting services, conducts development projects with partners, and establishes new companies built around strategic bundles of intellectual property. CCRM has a fully resourced research facility used to both evaluate and advance technologies, a centre for process development and advanced manufacturing, and a GMP facility within a 40,000 square foot space. CCRM is the commercialization partner of the University of Toronto’s Medicine by Design. CCRM is hosted by the University of Toronto and was launched in Toronto’s Discovery District on June 14, 2011.




Ranked among the world’s top engineering schools, the Faculty of Engineering plays a significant role in helping McMaster University earn its reputation as one of Canada’s most innovative universities. Our focus is on experiential, problem-based learning and our interdisciplinary approach to collaboration results in smarter insights, ground-breaking ideas and greater optimism. This approach is helping us create a Brighter World.  Visit for more information.

The McMaster School of Biomedical Engineering pushes the boundaries of discovery and improves the lives of future generations. The program has three areas of specialization; biomaterials and devices; imaging, sensing and detection; and therapeutics. We offer reputable graduate and PhD degree programs. Visit for more information.




Empowering Medtech Innovation® 

StarFish Medical is Canada’s award winning, full service Medical Device Design company providing engineering, design, development, NPI, commercialization and manufacturing services based in Victoria BC and Toronto. Our Pathfinder™ process reduces wasted effort and increases success for medical device product definition, technical engineering, and product development.  Prototype and volume production are delivered within an ISO 13485 certified Quality Management System, manufacturing and clean room facilities. Medical and specialty areas include: Bio Services, Microfluidics, Regenerative Medicine, Microbiology, Cardiovascular, Connected Devices, IVD, Ophthalmology, Optics, Point of Care Assays, and Ultrasound. 

MI Logo Color.jpg



Mobio Interactive is a digital therapeutics company that develops and commercializes clinically validated software to enhance human performance and help prevent, measure and treat mental illness. MI’s meditation and psychotherapy programs are distributed to patients via “AmDTx”, a digital therapeutic platform with embedded digital biomarkers.  The company is adopting the regulatory-approved and payor-reimbursed pharmaceutical model to digital therapeutics, leading to full integration of software as medicine into the healthcare economy. To date, MI has interventions developed or in development for seven indications: generalised anxiety, chronic stress diagnosis and treatment, mental illness comorbidity with cancer, paediatric traumatic brain injury, paediatric obesity, postpartum depression, and major depression.




Researchers at BC Children's Hospital Research Institute (BCCHR) save and transform children's lives through discovery, innovation, and excellence. Together with our generous and visionary partners, funders, and donors, and the families, families who participate in our research, we are at the forefront of child health. 

bottom of page